Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or revision in the estimated primary completion date for the study related to Pembrolizumab for Newly Diagnosed Glioblastoma.
    Difference
    0.1%
    Check dated 2024-05-10T08:32:43.000Z thumbnail image
  7. Check
    10 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a change in the estimated study completion date from April 30, 2026, to August 2026. This change likely indicates a shift in the timeline for the completion of the medical and healthcare-related study on Pembrolizumab for Newly Diagnosed Glioblastoma.
    Difference
    1%
    Check dated 2024-05-09T02:28:44.000Z thumbnail image
  8. Check
    18 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:47:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.